FDA inspection
Astellas Pharma Manufacturing, Inc.: FDA inspection ending Oct 31, 2008
FDA inspection 545070 · No Action Indicated (NAI) · Grand Island, NY
Key facts
| Inspection ID | 545070 |
|---|---|
| Firm | Astellas Pharma Manufacturing, Inc. |
| FEI number | 1317274 |
| Address | 3125 Staley Rd |
| City | Grand Island |
| State | NY |
| ZIP | 14072 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Oct 31, 2008 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data